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Edited by Gianni CesareniAbstract The p53-induced Wig-1 gene encodes a double
stranded RNA-binding zinc ﬁnger protein. We generated Saos-
2 osteosarcoma cells expressing tetracycline-inducible Flag-
tagged human Wig-1. Induction of Wig-1 expression by doxycy-
cline inhibited cell growth in a long-term assay but did not cause
any changes in cell cycle distribution nor increased fraction of
apoptotic cells. Using co-immunoprecipitation and mass spec-
trometry, we identiﬁed two Wig-1-binding proteins, hnRNP
A2/B1 and RNA Helicase A, both of which are involved in
RNA processing. The binding was dependent on the presence
of RNA. Our results establish a link between the p53 tumor sup-
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Wig-1 is a target of the p53 tumor suppressor [1]. p53 is a
transcription factor that triggers cell cycle arrest, apoptosis
and/or senescence in response to cellular stress [2]. This raises
the question whether Wig-1 is a downstream eﬀector in one or
more of these processes. Wig-1 has three Cys2His2-type zinc
ﬁnger domains that are highly conserved from ﬁsh to man
[1,3]. The structural features of the Wig-1 zinc ﬁngers are
shared with the RNA-binding proteins dsRBP-ZFa and JAZ.
We found that Wig-1 binds dsRNA with high aﬃnity and that
the ﬁrst and second zinc ﬁngers are necessary for binding to
dsRNA in living cells [4,5]. Exogenous Wig-1 causes a modest
growth inhibition in a colony formation assay [1].
hnRNPs participate in transcriptional regulation, mainte-
nance of telomere length, alternative pre-mRNA splicing and
pre-mRNA 3 0 end processing in the nucleus. In the cytoplasm,
hnRNPs can regulate mRNA localization, translation and
turnover [6]. hnRNP A2 (36 kDa) and B1 (38 kDa) are iso-
forms derived from the same gene and diﬀer by only 12 amino
acids, due to the presence of exon 2 in the B1 transcript [7].
Targeting of hnRNP A2/B1 promotes cell death in trans-
formed cells but not in primary cells [8], and suppression of
hnRNP A2 causes a non-apoptotic inhibition of cell prolifera-
tion [9].
RNA Helicase A (RHA, Nuclear DNA Helicase II
(NDHII)) is a 142 kDa nuclear helicase that is involved in pro-
cesses such as transcriptional regulation and RNA processing
[10]. Following transcriptional inhibition RHA is translocated
to the cytoplasm where it binds mRNAs and pre-mRNAs [11].
RHA is necessary for translation of selected mRNAs by rec-
ognising a 5 0 post-transcriptional control element [12].
Here we have generated Saos-2 cells carrying Tet-inducible
Wig-1 with the aim of examining the function of Wig-1 and
identifying potential partner proteins. We show that induction
of Wig-1 in these cells inhibits cell growth without any changes
in cell cycle distribution or increased apoptosis. Moreover, we
identiﬁed hnRNP A2/B1 and RHA as Wig-1-binding proteins.2. Materials and methods
2.1. Cells and cell culture
Saos-2 osteosarcoma cells expressing tetracycline-regulated Flag-
tagged Wig-1 have been described [4]. Cells were grown in Iscoves
modiﬁed Dulbeccos medium with 10% fetal bovine serum withblished by Elsevier B.V. All rights reserved.
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(Sigma–Aldrich, Germany), 2 mM L-glutamine and 40 lg/ml gentami-
cin (Invitrogen, BV, Netherlands). Wig-1 expression was induced by
adding 1 lg/ml doxycycline to the culture media for 48 h unless other-
wise stated.
2.2. Immunoﬂuorescence staining
Saos-2 Tet-on and Saos-2 Tet-on-Wig-1 cells were plated on cover
slips in 6-well plates, induced with doxycycline and stained with anti-
Flag M2 antibody (Stratagen, CA) [1]. Endogenous Wig-1 was stained
with Wig-1 antibody (Proteintech Group Inc., USA) in Saos-2 cells.
2.3. WST-1 proliferation assay
Cells cultured on 96-well plates in triplicates were analysed after 96 h
or 5 days for growth suppression using the WST-1 assay (Roche Diag-
nostics, Sweden). Absorbance of samples was measured at 490 nm.
2.4. FACS analysis
Cells were cultured in the absence or presence of doxycycline, ﬁxed
in 70% ethanol for 18 h at 4 C, pelleted and incubated in PBS with
propidium iodide and RNase A for 30 min at 37 C. DNA content
was analysed by ﬂow cytometry in a BD FACS cytometer (BD Biosci-
ences).
2.5. Immunoprecipitation and Western blotting
Cells were lysed in VS buﬀer (50 mMNaCl, 0,5% NP40, 1% protease
inhibitor cocktail (Sigma–Aldrich), 1 mM Na3VO4 and 10 mM Tris
pH 7.5) and rotated at 4 C for 15 min. Lysates were centrifuged at
12000 rpm for 10 min at 4 C, the supernatant was treated with
200 lg/ml RNase A at 30 C for 20 min, precleared overnight with pro-
tein A agarose (Amersham Pharmacia Biotech, Sweden or Invitrogen),
and incubated with antibody for 6 h. Thirty microliters of protein A
Sepharose (Sigma–Aldrich) or 15 ll protein A agarose (Invitrogen)
were added and incubated overnight. Proteins were separated on
10% SDS page gels, stained by Silverquest (Invitrogen), Coomassie
or blotted onto a Hybond ECL nitrocellulose membrane (Amersham
Pharmacia Biotech) for Western blotting. Antibodies for immunopre-
cipitation and Western were Flag M2 antibody (Stratagen), anti-RHA
(from Chee-Gun Lee, UMDNJ-New Jersey Medical School, NJ [13]),
anti-hnRNP A2/B1 (Santa Cruz, USA) 1:250, anti-Wig-1 (see [4]) or
anti-b-actin (Sigma–Aldrich). Ten microliters of protein G Dynabeads
(Dynal, Norway) was used for immunoprecipitations of endogenous
proteins.Fig. 1. Saos-2 cells expressing Tet-regulated Wig-1. (A) Western blot
analysis of Saos-2 Tet-on-Wig-1 cells cultured with the indicated
concentrations of doxycycline (upper panel), or harvested at the
indicated time points after induction with doxycycline (lower panel).
(B) Immunoﬂuorescence staining of Saos-2 Tet-on-Wig-1 cells with2.6. Mass spectrometry
Protein spots were excised and digested using a MassPrep robotic
protein handling system (Waters), digested with trypsin (modiﬁed; Pro-
mega, USA) and applied to plates for MALDI mass spectrometry in a
Voyager DE-PRO instrument (PE Applied Biosystems, USA) in posi-
tive ion reﬂection mode. The Protein Prospector web site (http://pros-
pector.ucsf.edu) was used for protein identiﬁcation.Flag antibody before and after induction with doxycycline. (C)
Immunoﬂuorescence staining of Saos-2 cells with Wig-1 antibody.
(D) Saos-2 Tet-on, Saos-2 Tet-on-Wig-1, Saos-2 Tet-on-ZF1pm and
Saos-2 Tet-on-ZF2pm cells were plated on 96-well plates in triplicates
in the presence or absence of 1 lg/ml doxycycline. Cells were analysed
after 5 days for growth suppression using the WST-1 cell proliferation
reagent. The graph shows percentage of cells cultured with doxycycline2.7. siRNA
siRNA oligos: Hs_WIG1_1_HP, Hs_WIG1_2_HP, Hs_HNRNPA
2B1_5_HP validated and AllStars Negative Control siRNA were used.
Transfections were carried out using HiPerFect (Qiagen, Germany)
according to manufacturers protocols.compared to cells cultured without.3. Results
3.1. Saos-2 cells expressing Tet-regulated Wig-1
We generated Saos-2 cells carrying Tet-inducible Flag-
tagged Wig-1. Western blotting demonstrated that expression
levels of Wig-1 correlated with the doxycycline concentration
in the medium (Fig. 1A). Immunoﬂuorescence staining showed
expression of Wig-1 in the nucleus of doxycycline-treated Saos-
2 Tet-on-Wig-1 cells (Fig. 1B), consistent with the nuclear
localization of endogenous wild-type Wig-1 (Fig. 1C). We also
generated Saos-2 cells carrying Tet-regulated Wig-1 zinc ﬁnger1 (ZF1) and zinc ﬁnger 2 (ZF2) point mutants, both of which
fail to bind dsRNA in living cells [4]. Cells expressing the ZF1
and ZF2 point mutants, referred to as Saos-2 Tet-on-ZF1pm
and Saos-2 Tet-on-ZF2pm, showed similar inducible expres-
sion as the wild-type Wig-1-carrying cells (not shown).
3.2. Wig-1 inhibits tumor cell growth without any eﬀect on cell
cycle distribution
We previously showed that Wig-1 inhibits growth in a col-
ony formation assay [1,4]. To examine the short and long-term
eﬀects of Wig-1 on cell growth and/or survival in further detail,
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(carrying only the tet-operator), and Saos-2 Tet-on-Wig-1 cells
with or without doxycycline. The Wig-1-expressing cultures
contained signiﬁcantly fewer cells as compared to the same
cells grown without doxycycline. We did not observe any sig-
niﬁcant growth inhibitory eﬀect of the ZF1pm and ZF2pmFig. 2. Wig-1 binds hnRNP A2/B1 and RHA, but not hnRNPK, via RNA.
cultured in the presence or absence of doxycycline were treated with RNas
blotting using indicated antibodies. (B, C) Protein lysates from Saos-2 Tet-o
doxycycline were immunoprecipitated with an hnRNP A2/B1 antibody (B) o
antibodies. (D) Protein lysates from MCF7 cells were immunoprecipitated
indicated antibodies. (E) Protein lysates from Saos-2 Tet-on and Saos-2 Tet-o
by Western blotting with indicated antibodies.point mutants (Fig. 1D), in agreement with our previous study
[4]. Saos-2 Tet-on and Saos-2 Tet-on-Wig-1 cells cultured in
the presence or absence of doxycycline for up to 14 days dis-
played no changes in cell cycle distribution or increase in the
fraction of cells with sub-G1 DNA content as judged by pro-
pidium iodide staining and FACS (data not shown).(A) Protein lysates from Saos-2 Tet-on and Saos-2 Tet-on-Wig-1 cells
e followed by immunoprecipitation with Flag antibody and Western
n and Saos-2 Tet-on-Wig-1 cells cultured in the presence or absence of
r an RHA antibody (C) followed by Western blotting using indicated
with b-actin or RHA antibodies followed by Western blotting with
n-Wig-1 cells were immunoprecipitated with a Flag antibody followed
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To identify Wig-1-binding proteins, we immunoprecipitated
Wig-1 using Flag antibody, separated proteins on an SDS poly-
acrylamide gel, and visualized protein bands by silver staining.
Several proteins were co-immunoprecipitated with Wig-1. The
two most prominent proteins with apparent molecular weights
of 38 and 140 kDa were cut out from a Coomassie-stained gel
and identiﬁed as hnRNP A2/B1 (36/38 kDa) and RNA Heli-
case A (RHA) (142 kDa) by MALDI mass spectrometry.
3.4. Wig-1 interacts with hnRNPA2/B1 and RHA via RNA
To verify binding, we immunoprecipitated Wig-1, hnRNP
A2/B1 or RHA from Saos-2 Tet-on-Wig-1 cells and analysed
co-immunoprecipitating proteins by Western blotting (Fig.
2A–C). We also found that the endogenous Wig-1, hnRNP
A2/B1 and RHA proteins form complexes in MCF7 cells
(Fig. 2D) and HEK293 cells (data not shown). The fact that
all three proteins bind dsRNA in living cells suggested that
they might interact through RNA. To investigate this, we trea-
ted lysates with RNase A prior to immunoprecipitation. This
treatment almost completely abolished the binding (Fig. 2A).
We conclude that the interaction of Flag-Wig-1 with hnRNP
A2/B1 and RHA is dependent on RNA. As a control forFig. 3. ZF1 and ZF2 point mutant forms of Wig-1 do not bind hnRNP A2/B
on-ZF1pm and Saos-2 Tet-on ZF2pm cells cultured in the presence or absenc
by Western blotting using indicated antibodies. (B) hnRNP A2/B1 and RH
treated with RNase followed by immunoprecipitation with RHA and Wester
transfected with the indicated siRNA in 96-well plates in triplicates and analy
reagent. The graph shows percentage of cells compared to siCon.unspeciﬁc RNA-mediated interactions, we assessed Wig-1
binding to the abundant RNA-binding protein hnRNP K.
Wig-1 did not bind hnRNP K (Fig. 2E).3.5. The ZF1 and ZF2 point mutants do not bind RHA or
hnRNP A2/B1
The ﬁrst and the second zinc ﬁnger domains of Wig-1 are
necessary for RNA binding in living cells [4]. To test if the
ZF1 and ZF2 mutants can bind hnRNP A2/B1 and/or RHA,
we performed immunoprecipitation experiments in the Saos-
2 Tet-on-ZF1pm and Saos-2 Tet-on-ZF2pm cells. Neither mu-
tant co-immunoprecipitated with RHA and hnRNP A2/B1
(Fig. 3A), conﬁrming that the interaction between Wig-1 and
hnRNP A2/B1 and RHA is dependent on RNA.3.6. RHA and hnRNP A2/B1 interact via RNA
Finally, we tested if hnRNP A2/B1 and RHA were able to
interact with each other via RNA. As shown in Fig. 3B,
hnRNP A2/B1 co-immunoprecipitated with the RHA anti-
body in HEK293 cells. The binding was abolished by RNase
A. Thus, hnRNP A2/B1 and RHA form a complex in
HEK293 cells which is dependent on RNA.1 nor RHA. (A) Protein lysates from Saos-2 Tet-on-Wig-1, Saos-2 Tet-
e of doxycycline were immunoprecipitated with Flag antibody followed
A interact with each other. A protein lysate from HEK293 cells was
n blotting with indicated antibodies. (C) HCT116 cells were plated and
sed after 96 h for growth suppression using the WST-1 cell proliferation
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To examine the eﬀect of Wig-1 knock-down, we treated
HCT116 colon carcinoma cells carrying wild-type p53 with
siRNA against Wig-1. Wig-1 knock-down caused a marked
growth inhibition as judged by the WST-1 proliferation assay
(Fig. 3C). Knockdown of hnRNP A2/B1 shows a similar, al-
beit slightly less pronounced eﬀect, as previously reported [9].
Interestingly, the simultaneous knockdown of both proteins
had a comparable eﬀect as knockdown of either of the two,
suggesting that they act in the same pathway (Fig. 3C). We ob-
tained similar data in Saos-2 cells using FACS-PI to assess the
sub-G1 (apoptotic) cell fraction. After 72 h of siRNA treat-
ment, a signiﬁcant diﬀerence was observed between siControl
and siWig-1, sihnRNP A2/B1, or siWig-1+ sihnRNP A2/B1,
whereas no signiﬁcant diﬀerences were observed between the
latter three in terms of fraction of sub-G1 cells after treatment
(data not shown).4. Discussion
The fact that Wig-1 is a p53 target gene [1,4,5,14] suggests
that it is involved in the p53 response to cellular stress. We
have previously demonstrated that Wig-1 inhibits cell growth
in a colony formation assay [1,4]. In order to further analyse
the eﬀects of Wig-1 expression in the absence of p53, we gen-
erated Saos-2 (p53 null) cells carrying tetracycline-regulated
human Wig-1. Our WST-1 assay demonstrated that Wig-1
has a modest eﬀect on cell growth. Surprisingly, we did not de-
tect any eﬀect of Wig-1 on cell cycle distribution or any in-
creased fraction of cells with sub-G1 DNA content. This
shows that Wig-1 does not inhibit cell growth by blocking cell
cycle progression or by triggering a major apoptotic response.
Our co-immunoprecipitation experiments identiﬁed hnRNP
A2/B1 and RHA as protein partners of Wig-1. This binding
was conﬁrmed in HEK293 and MCF7 cells expressing endog-
enous Wig-1. It requires RNA, since RNAse treatment abol-
ishes binding. Furthermore, the ZF1 and ZF2 point mutants,
which are deﬁcient for RNA binding in living cells, do not
interact with hnRNP A2/B1 and RHA, and are also unable
to inhibit cell growth. These ﬁndings suggest that Wig-1-med-
iated growth inhibition is somehow dependent on the binding
to hnRNP A2/B1 and RHA.
It remains to be elucidated which (groups of) dsRNA Wig-1
binds to in living cells. Therefore we can only speculate on the
possible link between the Wig-1 dsRNA binding and cell
growth and/or survival, and the roles of hnRNP A2/B1 and
RHA in these processes. We have shown here that both over-
expression and silencing of Wig-1 can inhibit cell growth.
Interestingly, downregulation of hnRNP A2/B1 also inhibits
cell growth without causing apoptosis [9]. Furthermore, we
show that knockdown of both Wig-1 and hnRNP A2/B1
simultaneously results in the same growth inhibitory eﬀect as
silencing either one alone, indicating that these two proteins
function in the same pathway. We speculate that p53 might
block hnRNP A2/B1 through Wig-1, thus inhibiting cell prolif-
eration by a previously unknown mechanism.
Our ﬁnding that Wig-1 interacts with RHA via RNA raises
the possibility that Wig-1 exerts its growth inhibitory eﬀects by
interfering with transcription, by acting on mRNA processing
at some level, or by interfering with the eﬀect of RHA ontranslation of target mRNAs. Additionally, it is conceivable
that Wig-1 and RHA and/or hnRNP A2/B1 are part of pro-
tein–RNA complexes that block transport of speciﬁc mRNAs
across the nuclear membrane, thereby inhibiting their transla-
tion into protein.
Our results provide a link between the p53 tumor suppressor
pathway and RNA processing via hnRNP A2/B1 and RHA.
p53, hnRNP A2/B1 and RHA are all multifunctional proteins
that are important for the survival of the cell. Therefore it is
plausible that they are functionally connected. Further studies
of the Wig-1–hnRNP A2/B1–RHA interactions will hopefully
provide a better understanding of the function of Wig-1 in the
p53 tumor suppressor pathway and the possible role of hnRNP
A2/B1 and RHA in regulation of cell growth and survival.
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